Shanker; Ravi M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shanker; Ravi M..The latest application filed is for "solid dosage forms of palbociclib".

Company Profile

1.49.58

Shanker; Ravi M. - Stonington CT
Shanker; Ravi M. - Groton CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Solid Dosage Forms Of Palbociclib App 20210315900 - Ibrahim; Fady Makram Louiz ; et al.	2021-10-14
Solid dosage forms of palbociclib Grant 11,065,250 - Ibrahim , et al. July 20, 2	2021-07-20
Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials Grant 10,357,455 - Perlman , et al. July 23, 2	2019-07-23
Compositions with a rheological modifier to reduce dissolution variability Grant 10,300,142 - Yum , et al.	2019-05-28
Compositions With A Rheological Modifier To Reduce Dissolution Variability App 20180339049 - Yum; Su Il ; et al.	2018-11-29
Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-forming Materials App 20180338915 - Perlman; Michael E. ; et al.	2018-11-29
Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials Grant RE47,033 - Babcock , et al. September 11, 2	2018-09-11
Compositions with a Rheological Modifier to Reduce Dissolution Variability App 20180236078 - Yum; Su Il ; et al.	2018-08-23
Solid Dosage Forms Of Palbociclib App 20180207100 - Ibrahim; Fady Makram Louiz ; et al.	2018-07-26
Compositions with a rheological modifier to reduce dissolution variability Grant 9,907,851 - Yum , et al. March 6, 2	2018-03-06
Compositions with a rheological modifier to reduce dissolution variability Grant 9,855,333 - Yum , et al. January 2, 2	2018-01-02
Compositions with a Rheological Modifier to Reduce Dissolution Variability App 20170209581 - Yum; Su Il ; et al.	2017-07-27
Compositions with a Rheological Modifier to Reduce Dissolution Variability App 20170196978 - Yum; Su Il ; et al.	2017-07-13
Compositions with a rheological modifier to reduce dissolution variability Grant 9,572,885 - Yum , et al. February 21, 2	2017-02-21
Compositions with a rheological modifier to reduce dissolution variability Grant 9,555,113 - Yum , et al. January 31, 2	2017-01-31
Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-forming Materials App 20170000733 - Perlman; Michael E. ; et al.	2017-01-05
Pharmaceutical Compositions Of Dispersions Of Drug And Neutral Polymers App 20160374945 - Friesen; Dwayne T. ; et al.	2016-12-29
Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials Grant 9,486,410 - Perlman , et al. November 8, 2	2016-11-08
Pharmaceutical compositions of dispersions of drug and neutral polymers Grant 9,468,604 - Friesen , et al. October 18, 2	2016-10-18
Pharmaceutical compositions providing enhanced drug concentrations Grant 9,457,095 - Curatolo , et al. October 4, 2	2016-10-04
Pharmaceutical dosage forms comprising a low-solubility drug and a polymer Grant 9,445,998 - Appel , et al. September 20, 2	2016-09-20
Compositions with a Rheological Modifier to Reduce Dissolution Variability App 20160038592 - Yum; Su Il ; et al.	2016-02-11
Pharmaceutical Compositions Providing Enhanced Drug Concentrations App 20150190518 - Curatolo; William J. ; et al.	2015-07-09
Process for annealing amorphous atorvastatin Grant 9,034,913 - Reddy , et al. May 19, 2	2015-05-19
Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials Grant 9,023,393 - Babcock , et al. May 5, 2	2015-05-05
Pharmaceutical compositions providing enhanced drug concentrations Grant 8,980,321 - Curatolo , et al. March 17, 2	2015-03-17
Pharmaceutical Dosage Forms Comprising A Low-solubility Drug And A Polymer App 20150064264 - Appel; Leah E. ; et al.	2015-03-05
Pharmaceutical solid dispersions Grant 8,883,209 - Babcock , et al. November 11, 2	2014-11-11
Pharmaceutical Compositions Providing Enhanced Drug Concentrations App 20140322325 - Curatolo; William J. ; et al.	2014-10-30
Compositions with a Rheological Modifier to Reduce Dissolution Variability App 20140275147 - Yum; Su Il ; et al.	2014-09-18
Pharmaceutical solid dispersions Grant 8,828,442 - Babcock , et al. September 9, 2	2014-09-09
Pharmaceutical compositions providing enhanced drug concentrations Grant 8,796,341 - Curatolo , et al. August 5, 2	2014-08-05
Pharmaceutical Compositions Of Dispersions Of Drug And Neutral Polymers App 20140210117 - Friesen; Dwayne T. ; et al.	2014-07-31
Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers Grant 8,703,196 - Babcock , et al. April 22, 2	2014-04-22
Pharmaceutical compositions of adsorbates of amorphous drug Grant 8,703,199 - Babcock , et al. April 22, 2	2014-04-22
Pharmaceutical Compositions Providing Enhanced Drug Concentrations App 20130345236 - Curatolo; William J. ; et al.	2013-12-26
Pharmaceutical compositions providing enhanced drug concentrations Grant 8,501,231 - Curatolo , et al. August 6, 2	2013-08-06
Pharmaceutical compositions of semi-ordered drugs and polymers Grant 8,491,933 - Babcock , et al. July 23, 2	2013-07-23
Pharmaceutical solid dispersions Grant 8,481,081 - Babcock , et al. July 9, 2	2013-07-09
Pharmaceutical compositions of adsorbates of amorphous drug Grant 8,389,006 - Babcock , et al. March 5, 2	2013-03-05
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors Grant 8,389,011 - Crew , et al. March 5, 2	2013-03-05
Pharmaceutical Solid Dispersions App 20130029965 - Babcock; Walter C. ; et al.	2013-01-31
Pharmaceutical Compositions Of Semi-ordered Drugs And Polymers App 20120322805 - Babcock; Walter C. ; et al.	2012-12-20
Pharmaceutical Compositions of Dispersions of Amorphous Drugs Mixed with Polymers App 20120295988 - Babcock; Walter C. ; et al.	2012-11-22
Pharmaceutical Compositions Of Cholesteryl Ester Transfer Protein Inhibitors App 20120277315 - Crew; Marshall D. ; et al.	2012-11-01
Pharmaceutical Compositions Providing Enhanced Drug Concentrations App 20120259022 - Curatolo; William J. ; et al.	2012-10-11
Pharmaceutical compositions of semi-ordered drugs and polymers Grant 8,257,739 - Babcock , et al. September 4, 2	2012-09-04
Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers Grant 8,236,328 - Babcock , et al. August 7, 2	2012-08-07
Pharmaceutical compositions providing enhanced drug concentrations Grant 8,202,912 - Curatolo , et al. June 19, 2	2012-06-19
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors Grant 8,197,848 - Crew , et al. June 12, 2	2012-06-12
Pharmaceutical compositions of drugs and neutralized acidic polymers Grant 8,173,142 - Crew , et al. May 8, 2	2012-05-08
Pharmaceutical compositions of drugs and neutralized acidic polymers Grant 8,147,872 - Crew , et al. April 3, 2	2012-04-03
Pharmaceutical Compositions Providing Enhanced Drug Concentrations App 20110294902 - CURATOLO; William J. ; et al.	2011-12-01
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitor Grant 8,048,452 - Curatolo , et al. November 1, 2	2011-11-01
Pharmaceutical compositions providing enhanced drug concentrations Grant 8,026,286 - Curatolo , et al. September 27, 2	2011-09-27
Dosage forms comprising a CETP inhibitors and an HMG-CoA reductase inhibitor Grant 7,897,175 - Friesen , et al. March 1, 2	2011-03-01
Pharmaceutical Solid Dispersions App 20100256110 - Babcock; Walter C. ; et al.	2010-10-07
Process for Annealing Amorphous Atorvastatin App 20090221667 - Reddy; Renuka D. ; et al.	2009-09-03
Pharmaceutical Dosage Forms Comprising A Low-solubility Drug And A Polymer App 20090142404 - Appel; Leah E. ; et al.	2009-06-04
Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers App 20090011024 - Babcock; Walter C. ; et al.	2009-01-08
Pharmaceutical Compositions of Adsorbates of Amorphous Drug App 20080292707 - Babcock; Walter C. ; et al.	2008-11-27
Solid Amorphous Dispersions of An Mtp Inhibitor For Treatment of Obesity App 20080293801 - Friesen; Dwayne T. ; et al.	2008-11-27
Pharmaceutical Compositions of Amorphous Dispersions of Drugs and Lipophilic Microphase-Forming Materials App 20080063708 - Perlman; Michael E. ; et al.	2008-03-13
Salts, Prodrugs and Formulations of 1-[5-(4-Amino-7-Isopropyl-7H-Pyrrolo[2,3-D]Pyrimidine-5-Carbonyl)-2-Metho- xy-Phenyl]-3-(2,4-Dichloro-Phenyl)-Urea App 20070287719 - Boyden; Tracy L. ; et al.	2007-12-13
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors App 20070282009 - Crew; Marshall D. ; et al.	2007-12-06
Pharmaceutical Compositions of Adsorbates of Amorphous Drug App 20070148236 - Babcock; Walter C. ; et al.	2007-06-28
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors Grant 7,235,259 - Crew , et al. June 26, 2	2007-06-26
4-Amino Substituted-2-Substituted-1,2,3,4-tetrahydroquinoline Compounds App 20060247272 - Ruggeri; Roger B. ; et al.	2006-11-02
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors Grant 7,115,279 - Curatolo , et al. October 3, 2	2006-10-03
Pharmaceutical Compositions of Dispersions of Drugs and Neutral Polymers App 20060216351 - Friesen; Dwayne T. ; et al.	2006-09-28
Pharmaceutical Compositions of Cholesteryl Ester Transfer Protein Inhibitor App 20060211654 - Curatolo; William J. ; et al.	2006-09-21
Pharmaceutical Compositions of Drugs and Neutralized Acidic Polymers App 20060204577 - Crew; Marshall D. ; et al.	2006-09-14
4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds App 20060063803 - Ruggeri; Roger B. ; et al.	2006-03-23
Pharmaceutical compositions of drugs and neutralized acidic polymers App 20060003011 - Crew; Marshall D. ; et al.	2006-01-05
Basic drug compositions with enhanced bioavailability App 20050049223 - Curatolo, William J. ; et al.	2005-03-03
Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials App 20050031693 - Babcock, Walter C. ; et al.	2005-02-10
Dosage forms comprising a CETP inhibitors and an HMG-CoA reductase inhibitor App 20040197398 - Friesen, Dwayne T. ; et al.	2004-10-07
Dosage forms comprising a CETP inhibitor and an HMG-CoA reductase inhibitor App 20040185102 - Friesen, Dwayne T. ; et al.	2004-09-23
Pharmaceutical compositions of semi-ordered drugs and polymers App 20040156905 - Babcock, Walter C. ; et al.	2004-08-12
Pharmaceutical solid dispersions App 20040013734 - Babcock, Walter C. ; et al.	2004-01-22
Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials App 20030228358 - Perlman, Michael E. ; et al.	2003-12-11
Glycogen phosphorylase inhibitor App 20030185891 - Crew, Marshall D. ; et al.	2003-10-02
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors App 20030186952 - Crew, Marshall D. ; et al.	2003-10-02
Pharmaceutical compositions containing polymer and drug assemblies App 20030170309 - Babcock, Walter C. ; et al.	2003-09-11
Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers App 20030104063 - Babcock, Walter C. ; et al.	2003-06-05
Pharmaceutical compositions of dispersions of drugs and neutral polymers App 20030091643 - Friesen, Dwayne T. ; et al.	2003-05-15
Basic drug compositions with enhanced bioavailability Grant 6,548,555 - Curatolo , et al. April 15, 2	2003-04-15
Pharmaceutical compositions of drugs and neutralized acidic polymers App 20030054038 - Crew, Marshall D. ; et al.	2003-03-20
Pharmaceutical compositions of adsorbates of amorphous drug App 20030054037 - Babcock, Walter C. ; et al.	2003-03-20
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors App 20020103225 - Curatolo, William J. ; et al.	2002-08-01
Pharmaceutical compositions providing enhanced drug concentrations App 20020006443 - Curatolo, William J. ; et al.	2002-01-17
Pharmaceutical compositions of glycogen phosphorylase inhibitors App 20010053778 - Hoover, Dennis J. ; et al.	2001-12-20
Glycogen phosphorylase inhibitor App 20010053791 - Babcock, Walter C. ; et al.	2001-12-20
Inclusion complexes of aryl-heterocyclic salts App 20010031756 - Kim, Yesook ; et al.	2001-10-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.